Nishimura, H
Novo Nordisk (Denmark)
2 papers on CoChatORCID 0000-0002-5622-5538
Most cited papers
- Verified
Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial
Yabe, D., Nakamura, J., Kaneto, H., Deenadayalan, S., Navarria, A., Gislum, M., Inagaki, N., Arisaka, T., Asakura, T., Azuma, N., et al. (2020) · The Lancet Diabetes & Endocrinology
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 210
- Verified
Association between serum organochlorines and global methylation level of leukocyte DNA among Japanese women: a cross-sectional study
Itoh, H., Iwasaki, M., Kasuga, Y., Yokoyama, S., Onuma, H., Nishimura, H., Kusama, R., Yoshida, T., Yokoyama, K., & Tsugane, S. (2014) · Science of The Total Environment
Epigenetics and DNA MethylationPesticide Exposure and Toxicity
Cited by 53
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free